Immediate Impact

1 from Science/Nature 27 standout
Sub-graph 1 of 9

Citing Papers

Harnessing innate immune pathways for therapeutic advancement in cancer
2024 Standout
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
2024 Standout
2 intermediate papers

Works of John Srouji being referenced

Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations
2021
Abstract 73: A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first-line non-squamous NSCLC: Associations with clinical outcomes
2021

Author Peers

Author Last Decade Papers Cites
John Srouji 34 27 11 19 3 44
Chrysa Papadopoulou 36 13 7 23 4 48
Hamid Khoja 39 45 10 24 2 60
Gwendoline Grondin 52 46 11 12 3 64
Kristin Vazzana 22 31 23 10 2 41
Lauren McCarl 23 15 12 18 3 51
Andrea Mahr 22 18 4 16 2 27
Tina Weinzierl 16 32 29 26 4 52
Loes Plaisier 24 23 20 15 2 45
Joerg Rinnenthal 12 23 8 23 3 37
Suzanna Rachimi 15 10 9 28 4 35

All Works

Loading papers...

Rankless by CCL
2026